Key facts
- This page summarizes Bruce Booth's Form 3 filing for Vigil Neuroscience, Inc. (VIGL).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Jan 2022, 19:30.
Bruce Booth - 06 Jan 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)
- Reporting relationship
- Director
- Issuer ticker
- VIGL
- Reported as of
- 06 Jan 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 06 Jan 2022, 19:30:53 UTC
- Prior SEC filing
- 12 Aug 2021
- Next SEC filing
- 11 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ommer Chohan, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Bruce Booth filed Form 3 for Vigil Neuroscience, Inc. (VIGL) on 06 Jan 2022.
Change
- Previous filing in this sequence was filed on 12 Aug 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIGL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,442,376
- Date
- 06 Jan 2022
- Ownership
- By Atlas Venture Fund XII, L.P.
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VIGL
holding
Derivative
Series A Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Jan 2022
- Ownership
- By Atlas Venture Fund XII, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 2,831,520
- Exercise price
- Footnotes
- F1, F2
VIGL
holding
Derivative
Series B Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Jan 2022
- Ownership
- By Atlas Venture Opportunity Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 1,027,978
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These shares are held directly by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII"). The general partner of Atlas Venture Fund XII is Atlas Venture Associates XII, L.P. ("AVA XII LP"). Atlas Venture Associates XII, LLC ("AVA XII LLC") is the general partner of AVA XII LP. The Reporting Person is a member of AVA XII LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund XII, except to the extent of his pecuniary interest therein, if any.
Footnote F2
These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") are convertible into Common Stock on a one-for-2.7732 basis at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
Footnote F3
The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any.
SEC remarks
Exhibit 24 - Power of Attorney